Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised over $230M in Series B financing. The ...
Tessera Therapeutics is planning to lay off 90 employees, the Flagship-founded biotech has warned. In a state layoff notice posted Wednesday, Tessera explained that the workforce reduction will affect ...
Elon Musk’s SpaceX is weighing an initial public offering (IPO) at a valuation of over $1.5 trillion. Microsoft-backed OpenAI is also rumored to be seeking a trillion-dollar public debut. Given that ...
Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million for its trio of gene writing platforms. The latest ...
It has been a busy few months at Tessera’s DigitalOptics subsidiary. At this year’s Mobile World Congress, they demonstrated some of the most innovative technology I saw at Mobile World Congress, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results